Skip to content
UChicagoCancerCenter· @UCCancerCenter · X·· 2026-04-21Score60
Body

At #AACR26, Yijia Sun presents validation data supporting performance of recently developed PRS. Importantly, a new streamlined 162-SNP TNBC PRS demonstrate consistent, cost-efficient potential that can advance more equitable and precise risk assessment. ⁦
@UChicagoPHS
⁩

Heat 4 · 2 likes · 0 replies · 2 reposts

Source: UChicagoCancerCenter · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org